GLP-1 Drugs – to Cover or Not to Cover

GLP-1 drugs, e.g., Wegovy and Ozempic, were originally developed for diabetes management, but they are now being taken for weight control. While they are not currently covered by most insurers, the insurance industry opinion is that they likely will be covered within a year or so because they have a beneficial effect on employees’ health, thereby reducing other potential costs. Stay tuned…

Previous
Previous

Room for Improvement in Communicating Employee Benefits

Next
Next

Discouraging News on the Health Front